TINA KAUDERER: Open Payments
NPI 1366763468 · CASTLE ROCK, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,609 in 79 payments from 11 companies in 2025. Trend: 2023 $1,035 · 2024 $1,398 · 2025 $1,609
Food & beverage: $1,609
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 13 | $507 |
| Teva Pharmaceuticals USA, Inc. | 8 | $283 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $219 |
| Janssen Pharmaceuticals, Inc | 4 | $181 |
| ABBVIE INC. | 18 | $147 |
| Vanda Pharmaceuticals Inc. | 5 | $113 |
| Otsuka America Pharmaceutical, Inc. | 4 | $63 |
| Alkermes, Inc. | 2 | $46 |
| Dexcom, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $17 |
Products named: Auvelity, UZEDY, CAPLYTA, SPRAVATO, VRAYLAR, FANAPT, REXULTI, ARISTADA.
Industry payments across CO — which companies pay providers there.
